Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NGen Oral Pharma was a biotechnology company based in Curacao, specializing in the development and commercialization of innovative oral healthcare products. The company's core technology, Ardox-X (AX), is a patented hydro-carbon-oxo-borate compound that releases active oxygen in a controlled manner to provide anti-microbial, anti-inflammatory, and teeth-whitening benefits. NGen Oral Pharma's product line, marketed under the brand O7 Active, includes mouthwashes, toothpastes, and gels designed to treat conditions such as periodontitis and peri-implantitis by selectively targeting anaerobic bacteria in oral biofilms. In 2023, the company was dissolved, and its O7 Active brand is now managed by Sunstar, a global leader in oral care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NGen Oral Pharma.